Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TRR237)
Deutsche Forschungsgemeinschaft (EXC2151 – 390873048)
Deutsche Forschungsgemeinschaft (SFB670)
Deutsche Forschungsgemeinschaft (GRK2168)
Deutsche Forschungsgemeinschaft (TRR237)
Deutsche Forschungsgemeinschaft (EXC2151 – 390873048)
Deutsche Forschungsgemeinschaft (SFB670)
Deutsche Forschungsgemeinschaft (GRK2168)
Deutsche Forschungsgemeinschaft (DFG SCHL1930/1-2)
BONFOR, Medical Faculty, University Hospital, University of Bonn
- License Information
-
More Information
Article History
Received: 21 April 2021
Revised: 5 June 2021
Accepted: 20 June 2021
First Online: 9 July 2021
Competing interests
: Anna-Maria Herzner is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.
